The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.
Analyst is bullish on Vertex Pharmaceuticals, citing FDA approval for JOURNAVX and strong earnings growth potential in 2025.
Daily Voice Tolland County CT on MSN4h
FDA Approves First Non-Opioid Painkiller In 20+ Years: 'A Historic Milestone'The Food and Drug Administration has approved a first-of-its-kind non-opioid pain medication, providing a new option for ...
Kratom has been used for hundreds of years in Southeast Asia for issues like fatigue. But it's banned in at least 6 states.
KELOLAND News on MSN8d
House OKs stricter kratom regs and warning labelThe South Dakota House of Representatives set aside political differences on Wednesday and found a topic that all of the ...
The Food and Drug Administration on Thursday approved a new type of nonopioid painkiller from Vertex Pharmaceuticals, NBC News reported.
Kratom is known for its stimulant and opioid-like effects and is derived from the leaves of a tree in the coffee family, the Southeast Asian tree Mitragyna speciosa. This differs from another natural ...
CBS News on MSN13d
Junk food under the gun as forces in Washington align to Make America Healthy AgainSimilar allegations were made against opioid manufacturers, distributors, and retailers before they agreed to pay tens of ...
The newest treatment for AUD, acamprosate (Campral) was developed in France. The FDA approved the drug for abstinence ...
Proposed legislation requiring alcohol warning labels will be studied once Parliament resumes says Sen. Patrick Brazeau.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback